These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 28447743)

  • 41. The relation of serum anti-(GalNAc beta) and -para-Forssman disaccharide IgG levels to the progression and histological grading of gastrointestinal cancer.
    Smorodin EP; Kurtenkov OA; Sergeyev BL; Chuzmarov VI; Afanasyev VP
    Exp Oncol; 2007 Mar; 29(1):61-6. PubMed ID: 17431391
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Flow cytometry-based assay to evaluate human serum MUC1-Tn antibodies.
    Van Elssen CH; Clausen H; Germeraad WT; Bennet EP; Menheere PP; Bos GM; Vanderlocht J
    J Immunol Methods; 2011 Feb; 365(1-2):87-94. PubMed ID: 21194532
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Development and application of a double- antibody sandwich ELISA kit for the detection of serum MUC1 in lung cancer patients.
    Wang J; Zhang S; Ni W; Zhai X; Xie F; Yuan H; Gao S; Tai G
    Cancer Biomark; 2016; 17(4):369-376. PubMed ID: 27636855
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Serum p53 antibody in breast cancer.
    Yamamoto S; Chishima T; Adachi S; Harada F; Toda Y; Arioka H; Hasegawa N; Kakuta Y
    Cancer Biomark; 2014; 14(4):203-6. PubMed ID: 24934362
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Generation and characterization of a high-affinity monoclonal antibody for MUC1 measurement in breast cancer.
    Hamid SS; Cheah SH
    Hybridoma (Larchmt); 2011 Apr; 30(2):137-43. PubMed ID: 21529286
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Humoral immune response to polymorphic epithelial mucin (MUC-1) in patients with benign and malignant breast tumours.
    von Mensdorff-Pouilly S; Gourevitch MM; Kenemans P; Verstraeten AA; Litvinov SV; van Kamp GJ; Meijer S; Vermorken J; Hilgers J
    Eur J Cancer; 1996 Jul; 32A(8):1325-31. PubMed ID: 8869094
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A genetic variant of immunoglobulin gamma2 is strongly associated with immunity to mucin 1 in patients with breast cancer.
    Pandey JP; Nietert PJ; Klaamas K; Kurtenkov O
    Cancer Immunol Immunother; 2009 Dec; 58(12):2025-9. PubMed ID: 19365631
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Direct detection and quantitation of a distinct T-cell epitope derived from tumor-specific epithelial cell-associated mucin using human recombinant antibodies endowed with the antigen-specific, major histocompatibility complex-restricted specificity of T cells.
    Cohen CJ; Hoffmann N; Farago M; Hoogenboom HR; Eisenbach L; Reiter Y
    Cancer Res; 2002 Oct; 62(20):5835-44. PubMed ID: 12384546
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Elevated CA125 in breast cancer--A sign of advanced disease.
    Norum LF; Erikstein B; Nustad K
    Tumour Biol; 2001; 22(4):223-8. PubMed ID: 11399947
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Detection of circulating mammary mucin (Muc1) and MUC1 immune complexes (Muc1-CIC) in healthy women.
    Croce MV; Isla-Larrain MT; Price MR; Segal-Eiras A
    Int J Biol Markers; 2001; 16(2):112-20. PubMed ID: 11471893
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Evaluation of CA 15-3 tumor marker in the diagnosis of breast cancer. A pilot study.
    Wojtacki J; Dziewulska-Bokiniec A; Skokowski J; Ciesielski D
    Neoplasma; 1994; 41(4):213-6. PubMed ID: 7935994
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Verification of WFA-Sialylated MUC1 as a Sensitive Biliary Biomarker for Human Biliary Tract Cancer.
    Yamaguchi T; Yokoyama Y; Ebata T; Matsuda A; Kuno A; Ikehara Y; Shoda J; Narimatsu H; Nagino M
    Ann Surg Oncol; 2016 Feb; 23(2):671-7. PubMed ID: 26416714
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The production and preclinical characterization of a chimeric anti-breast-cancer antibody, cBC2.
    Sutton VR; Burgess J; Pietersz GA; Li WJ; McKenzie IF; Trapani JA
    Ther Immunol; 1994 Apr; 1(2):83-93. PubMed ID: 7584487
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Isolation of MUC1-primed B lymphocytes from tumour-draining lymph nodes by immunomagnetic beads.
    Petrarca C; Casalino B; von Mensdorff-Pouilly S; Rughetti A; Rahimi H; Scambia G; Hilgers J; Frati L; Nuti M
    Cancer Immunol Immunother; 1999 Jan; 47(5):272-7. PubMed ID: 10022471
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Detection of MUC1-expressing mammary carcinoma cells in the peripheral blood of breast cancer patients by real-time polymerase chain reaction.
    de Cremoux P; Extra JM; Denis MG; Pierga JY; Bourstyn E; Nos C; Clough KB; Boudou E; Martin EC; Müller A; Pouillart P; Magdelénat H
    Clin Cancer Res; 2000 Aug; 6(8):3117-22. PubMed ID: 10955792
    [TBL] [Abstract][Full Text] [Related]  

  • 56. High-titer HER-2/neu protein-specific antibody can be detected in patients with early-stage breast cancer.
    Disis ML; Pupa SM; Gralow JR; Dittadi R; Menard S; Cheever MA
    J Clin Oncol; 1997 Nov; 15(11):3363-7. PubMed ID: 9363867
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Randomized phase II trial of letrozole plus anti-MUC1 antibody AS1402 in hormone receptor-positive locally advanced or metastatic breast cancer.
    Ibrahim NK; Yariz KO; Bondarenko I; Manikhas A; Semiglazov V; Alyasova A; Komisarenko V; Shparyk Y; Murray JL; Jones D; Senderovich S; Chau A; Erlandsson F; Acton G; Pegram M
    Clin Cancer Res; 2011 Nov; 17(21):6822-30. PubMed ID: 21878535
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The combined treatment with novel platinum(II) complex and anti-MUC1 increases apoptotic response in MDA-MB-231 breast cancer cells.
    Gornowicz A; Bielawska A; Czarnomysy R; Gabryel-Porowska H; Muszyńska A; Bielawski K
    Mol Cell Biochem; 2015 Oct; 408(1-2):103-13. PubMed ID: 26112902
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Potential for novel MUC1 glycopeptide-specific antibody in passive cancer immunotherapy.
    Madsen CB; Wandall HH; Pedersen AE
    Immunopharmacol Immunotoxicol; 2013 Dec; 35(6):649-52. PubMed ID: 24063621
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Molecular detection of telomerase-positive circulating epithelial cells in metastatic breast cancer patients.
    Soria JC; Gauthier LR; Raymond E; Granotier C; Morat L; Armand JP; Boussin FD; Sabatier L
    Clin Cancer Res; 1999 May; 5(5):971-5. PubMed ID: 10353728
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.